BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12407694)

  • 1. Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy.
    Popescu NC; Zimonjic DB
    Am J Med Genet; 2002 Oct; 115(3):142-9. PubMed ID: 12407694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
    Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi OP
    Semin Cancer Biol; 2001 Oct; 11(5):395-401. PubMed ID: 11562182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer.
    Buness A; Kuner R; Ruschhaupt M; Poustka A; Sültmann H; Tresch A
    Bioinformatics; 2007 Sep; 23(17):2273-80. PubMed ID: 17599933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene expression profiles in the diagnosis and prognosis of cancer].
    Kopper L; Tímár J
    Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women.
    Valladares A; Hernández NG; Gómez FS; Curiel-Quezada E; Madrigal-Bujaidar E; Vergara MD; Martínez MS; Arenas Aranda DJ
    Cancer Genet Cytogenet; 2006 Oct; 170(2):147-51. PubMed ID: 17011986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in breast cancer.
    Morris SR; Carey LA
    Curr Opin Oncol; 2007 Nov; 19(6):547-51. PubMed ID: 17906450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic implications of advances in breast cancer biology].
    Bertucci F; Gonçalves A; Maraninchi D
    Rev Prat; 2004 Apr; 54(8):865-70. PubMed ID: 15274460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of breast cancer by array comparative genomic hybridization.
    Climent J; Garcia JL; Mao JH; Arsuaga J; Perez-Losada J
    Biochem Cell Biol; 2007 Aug; 85(4):497-508. PubMed ID: 17713584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling familial breast cancer.
    Lakhani SR; O'Hare MJ; Ashworth A
    Nat Med; 2001 Apr; 7(4):408-10. PubMed ID: 11283660
    [No Abstract]   [Full Text] [Related]  

  • 18. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
    Melchor L; Benítez J
    Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of breast cancer.
    Paik S
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):59-63. PubMed ID: 16493262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.